Related Experiment Video
Updated: Aug 21, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
[Arterial hypertension in chronic glomerulonephritis: detectability and treatment efficacy]
Insights
Arterial hypertension (AH) is common in chronic glomerulonephritis (CGN), linked to kidney damage and function. Angiotensin-converting enzyme (ACE) inhibitors are the preferred treatment for AH in CGN patients.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Arterial hypertension (AH) is a significant comorbidity in patients with chronic glomerulonephritis (CGN).
- Understanding the prevalence and contributing factors of AH in CGN is crucial for effective management.
- Previous studies have highlighted the complex interplay between renal disease and hypertension.
Purpose of the Study:
- To determine the prevalence of arterial hypertension (AH) in patients with chronic glomerulonephritis (CGN).
- To investigate the relationship between AH, renal process activity, and renal function in CGN patients.
- To analyze the trends and efficacy of antihypertensive therapy in this population.
Main Methods:
- A cohort of 250 CGN patients treated between 1993 and 2001 was studied.
- Patients with various morphological variants of CGN were included.
- Antihypertensive treatment policies and patient outcomes were monitored throughout the study period.
Main Results:
- AH was highly prevalent, particularly in mesangiocapillary (96.6%) and diffuse fibroplastic nephritis (83.9%).
- Hypertension occurred in 90.1% of patients with renal functional insufficiency.
- AH correlated with nephritis activity, tubulointerstitial damage, and metabolic disturbances; age and uric acid were independent predictors.
Conclusions:
- Arterial hypertension is a frequent complication of CGN, influenced by nephritis type, activity, and renal failure severity.
- Age, gender, and metabolic factors contribute to AH development in CGN.
- ACE inhibitors are the drugs of choice for renal AH, with a trend towards increased use of combination therapy.
Aim:
To study prevalence of arterial hypertension (AH) in patients with chronic glomerulonephritis (CGN), its relationship with activity of the renal process, renal function; to analyse policy and efficacy of antihypertensive therapy. MATERIAL AND METHODS A total of 250 CGN patients treated in 1993-2001 participated in the trial. They had different morphological variants of CGN. AH was diagnosed in 193 patients. In the course of the trial changes in antihypertensive treatment policy were observed.
Results:
AH was most prevalent in mesangiocapillary (96.6%) and diffuse fibroplastic nephritis (83.9%). In functional insufficiency of the kidneys AH occurred in 90.1%. AH was associated with clinical and morphological signs of nephritis activity, severity of tubulointerstitial alterations, purin and lipid metabolism. Uric acid level and age were independent prognostic factors of AH development. AH correction was achieved in the initial and subsequent periods in 51.7 and 58.7% cases. Later, ACE inhibitors were prescribed more often, both in monotherapy and in combination with other drugs; calcium antagonists were taken less frequently.
Conclusion:
AH in CGN patients is a frequent finding and depends on a morphological nephritis variant, activity of the renal process and degree of renal failure. Age, gender and metabolic disorders are also involved in AH development in CGN patients. Recently, there is a trend to more frequent prescription of combined treatment. Drugs of choice in the treatment of renal AH are ACE inhibitors.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology